Emma Mendelsohn

Emma Mendelsohn

Auto-generated profile, based on publicly available information

Emma Mendelsohn

EcoHealth Alliance

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Environment International
Verified
Journal Article
Closed access
EMEmma Mendelsohn
Emma Mendelsohn
AHAudrey Hagopian
Audrey Hagopian
KHKate Hoffman
Kate Hoffman
CBCraig M. Butt
Craig M. Butt
ALAmelia Lorenzo
Amelia Lorenzo
HSHeather M. Stapleton
Heather M. Stapleton

8 February 2017 in Environmental Science & Technology Letters
Verified
Journal Article
Open access
KHKate Hoffman
Kate Hoffman
CBCraig M. Butt
Craig M. Butt
TWThomas F. Webster
Thomas F. Webster
Emma V PrestonEmma V Preston
Emma V Preston
SHStephanie C. Hammel
Stephanie C. Hammel
HSHeather M. Stapleton
Heather M. Stapleton
During the past decade, use of organophosphate compounds as flame retardants and plasticizers has increased. Numerous studies investigating biomarkers (i.e., urinary metabolites) demonstrate ubiquitous human exposure and suggest that human exposure may be increasing. To formally assess temporal trends, we combined data from 14 U.S. epidemiologic studies for which our laboratory group previously assessed exposure to two commonly used organophosphate compounds, tris(1,3-dichloro-2-propyl) phosphate (TDCIPP) and triphenyl phosphate (TPHP). Using individual-level data and samples collected between 2002 and 2015, we assessed temporal and seasonal trends in urinary bis(1,3-dichloro-2-propyl) phosphate (BDCIPP) and diphenyl phosphate (DPHP), the metabolites of TDCIPP and TPHP, respectively. Data suggest that BDCIPP concentrations have increased dramatically since 2002. Samples collected in 2014 and 2015 had BDCIPP concentrations that were more than 15 times higher than those collected in 2002 and 2003 (10β = 16.5; 95% confidence interval from 9.64 to 28.3). Our results also demonstrate significant increases in DPHP levels; however, increases were much smaller than for BDCIPP. Additionally, results suggest that exposure varies seasonally, with significantly higher levels of exposure in summer for both TDCIPP and TPHP. Given these increases, more research is needed to determine whether the levels of exposure experienced by the general population are related to adverse health outcomes.

1 September 2019 in Biosafety and Health
Verified
Journal Article
Open access
HLHongying Li
Hongying Li
EMEmma Mendelsohn
Emma Mendelsohn
CZChen Zong
Chen Zong
WZWei Zhang
Wei Zhang
EHEmily Hagan
Emily Hagan
PDPeter Daszak
Peter Daszak
Human interaction with animals has been implicated as a primary risk factor for several high impact zoonoses, including many bat-origin viral diseases. However the animal-to-human spillover events that lead to emerging diseases are rarely observed or clinically examined, and the link between specific interactions and spillover risk is poorly understood. To investigate this phenomenon, we conducted biological-behavioral surveillance among rural residents in Yunnan, Guangxi, and Guangdong districts of Southern China, where we have identified a number of SARS-related coronaviruses in bats. Serum samples were tested for four bat-borne coronaviruses using newly developed enzyme-linked immunosorbent assays (ELISA). Survey data were used to characterize associations between human-animal contact and bat coronavirus spillover risk. A total of 1,596 residents were enrolled in the study from 2015 to 2017. Nine participants (0.6%) tested positive for bat coronaviruses. 265 (17%) participants reported severe acute respiratory infections (SARI) and/or influenza-like illness (ILI) symptoms in the past year, which were associated with poultry, carnivore, rodent/shrew, or bat contact, with variability by family income and district of residence. This study provides serological evidence of bat coronavirus spillover in rural communities in Southern China. The low seroprevalence observed in this study suggests that bat coronavirus spillover is a rare event. Nonetheless, this study highlights associations between human-animal interaction and zoonotic spillover risk. These findings can be used to support targeted biological behavioral surveillance in high-risk geographic areas in order to reduce the risk of zoonotic disease emergence.

1 July 2015 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
LKLuda Kopelovich
Luda Kopelovich
APAngela L. Perez
Angela L. Perez
NJNeva Jacobs
Neva Jacobs
EMEmma Mendelsohn
Emma Mendelsohn
JKJames J. Keenan
James J. Keenan

20 September 2023 in Proceedings Of The Royal Society B-Biological Sciences
Verified
Journal Article
Open access
EMEmma Mendelsohn
Emma Mendelsohn
NRNoam Ross
Noam Ross
CZCarlos Zambrana-Torrelio
Carlos Zambrana-Torrelio
TBThomas P. Van Boeckel
Thomas P. Van Boeckel
RLRamanan Laxminarayan
Ramanan Laxminarayan
PDPeter Daszak
Peter Daszak
Antimicrobial resistance (AMR) is a critical global health threat, and drivers of the emergence of novel strains of antibiotic-resistant bacteria in humans are poorly understood at the global scale. We examined correlates of AMR emergence in humans using global data on the origins of novel strains of AMR bacteria from 2006 to 2017, human and livestock antibiotic use, country economic activity and reporting bias indicators. We found that AMR emergence is positively correlated with antibiotic consumption in humans. However, the relationship between AMR emergence and antibiotic consumption in livestock is modified by gross domestic product (GDP), with only higher GDP countries showing a slight positive association, a finding that differs from previous studies on the drivers of AMR prevalence. We also found that human travel may play a role in AMR emergence, likely driving the spread of novel AMR strains into countries where they are subsequently detected for the first time. Finally, we used our model to generate a country-level map of the global distribution of predicted AMR emergence risk, and compared these findings against reported AMR emergence to identify gaps in surveillance that can be used to direct prevention and intervention policies.

21 June 2021 in F1000Research
Verified
Journal Article
Open access
PDF file
EMEmma Mendelsohn
Emma Mendelsohn
NRNoam Ross
Noam Ross
AWAllison M. White
Allison M. White
KWKarissa Whiting
Karissa Whiting
CBCale Basaraba
Cale Basaraba
PDPeter Daszak
Peter Daszak
Despite considerable global surveillance of antimicrobial resistance (AMR), data on the global emergence of new resistance genotypes in bacteria has not been systematically compiled. We conducted a study of English-language scientific literature (2006-2017) and ProMED-mail disease surveillance reports (1994-2017) to identify global events of novel AMR emergence (first clinical reports of unique drug-bacteria resistance combinations). We screened 24,966 abstracts and reports, ultimately identifying 1,757 novel AMR emergence events from 268 peer-reviewed studies and 26 disease surveillance reports (294 total). Events were reported in 66 countries, with most events in the United States (152), China (128), and India (127). The most common bacteria demonstrating new resistance were Klebsiella pneumoniae (344) and Escherichia coli (218). Resistance was most common against antibiotic drugs imipenem (89 events), ciprofloxacin (84) and ceftazidime (83). We provide an open-access database of emergence events with standardized fields for bacterial species, drugs, location, and date. We discuss the impact of reporting and surveillance bias on database coverage, and we suggest guidelines for data analysis. This database may be broadly useful for understanding rates and patterns of AMR evolution, identifying global drivers and correlates, and targeting surveillance and interventions.